Digicann Ventures Announces Proposed Reverse Takeover Transaction with Winning Asia Technology Macau Limited
Newsfile
48 minutes ago
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company"), is a reporting issuer listed on the Canadian Securities Exchange (the "CSE"). The Company is currently focused on ident
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
1 hours ago
$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if war
Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems
GlobeNewswire Inc.
1 hours ago
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetesNew data and real-world findings further emphasize pediatric safety, glycemic control and treatment sat
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
GlobeNewswire Inc.
2 hours ago
Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a once-daily oral pill for the treatment of obesity and overweightAdditional data from Phase 2 obesity clinic
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
GlobeNewswire Inc.
2 hours ago
•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 recepto
South Pacific Metals Engages Marketing Services and Grants Stock Options
Newsfile
2 hours ago
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - South Pacific Metals Corp. (TSXV: SPMC) (OTCQB: SPMEF) (FSE: 6J00) ("SPMC" or "South Pacific Metals" or the "Company") announces that it has entered into an online marketing agreement dat
Street Capital Inc. Announces Resignation of Tabitha Fritz
Newsfile
2 hours ago
Toronto, Ontario--(Newsfile Corp. - June 5, 2026) - Street Capital Inc. (the "Company") announces that, effective May 28, 2026, Tabitha Fritz has resigned from her position as a member of the Company's Board of Directors and Audit Committee. The Comp
Custom Health Holdings Inc. Announces Completion of Plan of Arrangement
Newsfile
3 hours ago
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Custom Health Holdings Inc. (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release dated May 13, 2026, is pleased to announce the successful comp
Charlotte's Web Announces Board Transition as Co-Founder Jared Stanley Deepens Focus on DeFloria
Newsfile
3 hours ago
Mr. Stanley to dedicate his full attention to advancing DeFloria's FDA Phase 2 botanical drug program, a Charlotte's Web-affiliated clinical-stage ventureLouisville, Colorado--(Newsfile Corp. - June 5, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWE
District Announces Equity Grant
Newsfile
4 hours ago
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - District Metals Corp. (TSXV: DMX) (Nasdaq First North: DMXSE SDB) (OTCQX: DMXCF) (FSE: DFPP); ("District" or the"Company") announces that it has granted a total of 2,820,000 incentive sto

